Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

IGF2/H19 hypomethylation in a patient with very low birthweight, preocious pubarche and insulin resistance

  • Rinki Murphy1Email author,
  • Lourdes Ibáñez2,
  • Andrew Hattersley3 and
  • Jörg Tost4
BMC Medical Genetics201213:42

DOI: 10.1186/1471-2350-13-42

Received: 15 December 2011

Accepted: 8 May 2012

Published: 30 May 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
15 Dec 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
4 Mar 2012 Reviewed Reviewer Report - Monica Miozzo
14 Mar 2012 Reviewed Reviewer Report - Jennifer Frost
10 Apr 2012 Author responded Author comments - Rinki Murphy
Resubmission - Version 3
10 Apr 2012 Submitted Manuscript version 3
11 Apr 2012 Reviewed Reviewer Report - Jennifer Frost
25 Apr 2012 Reviewed Reviewer Report - Monica Miozzo
6 May 2012 Author responded Author comments - Rinki Murphy
Resubmission - Version 4
6 May 2012 Submitted Manuscript version 4
Publishing
8 May 2012 Editorially accepted
30 May 2012 Article published 10.1186/1471-2350-13-42

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Faculty of Medical and Health Sciences, University of Auckland
(2)
Endocrinology Unit, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, and Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), ISCIII
(3)
Institute of Biomedical and Clinical Sciences, Peninsula Medical School
(4)
Laboratory for Epigenetics, Centre National de Génotypage, CEA-Institut de Génomique

Advertisement